Unapproved New Drugs
Similar Posts
2024 Safety Communications
Listing of Medical Device 2024 Safety CommunicationsSeaway Pharma Inc. – 717355 – 12/01/2025
CGMP/Finished Pharmaceuticals/AdulteratedNostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Sucralfate Tablets USP 1 Gram Within Expiry
Nostrum Laboratories, Inc. (“Nostrum Labs”) filed Chapter 11 bankruptcy on September 30, 2024. In connection with that filing, the company has ceased and shutdown operations and terminated its operational employees at all domestic U.S. sites. Nostrum Labs is initiating a voluntary recall of SucralfaInformation by Drug Class
FDA provides consumers and industry with safety, regulatory and availability information for various drugs by drug class. From A to Z. Topics include: acetaminophen, estrogen, insulin, opioids, statins, and weight-loss drugs.Laboratory Information Bulletins
Laboratory Information Bulletins available to the publicDiagnostic Intravascular Catheter Recall: Conavi Removes Novasight Hybrid Catheters
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program